Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "New York University Langone Health"


5 mentions found


Donald Trump claimed in an interview on CNBC that he had "never been a fan" of Home Depot co-founder Ken Langone, the billionaire investor who endorsed the former president's primary challenger, Nikki Haley. "Well, look, I've never been a fan of Ken," Trump said. Trump and Langone were in contact in 2020 during the coronavirus pandemic, according to archived records of the former president's schedule. In a separate interview in January, Langone said he would not support Trump if the former president were the Republican nominee. Langone co-founded Home Depot over 40 years ago, and he has a net worth of over $8 billion, according to Forbes.
Persons: Donald Trump, Ken Langone, Nikki Haley, Trump's, it's, Langone, I've, Ken, Trump Organizations: CNBC, Depot, Trump, Republican, Haley, PAC, South, GOP, Forbes, New York University Langone Health Locations: South Carolina
CNN —New advancements in transplanting pig kidneys to humans, detailed by two separate research teams on Wednesday, mark key steps forward in the evolving field of xenotransplantation, the use of non-human tissues or organs to treat medical conditions in humans. Both research teams used genetically modified pig kidneys that were transplanted into recipients experiencing brain death in what is considered pre-clinical human research. Other studies have demonstrated that this can occur when pig kidneys are transplanted in non-human primates. The team has been monitoring pig kidney transplants in a brain-dead decedent – a man named Maurice Miller, known as Mo, who died of a brain tumor – for nearly two months. “Over the last 20 years, we’ve gained a lot of information about how pig kidneys work to replace the functions in primates.
Persons: , Jayme Locke, Locke, ” Locke, NYU Langone, Maurice Miller, Mo, Robert Montgomery, Dr, Sanjay Gupta, “ We’re, Adam Griesemer, we’ve, ’ –, we’re Organizations: CNN, University of Alabama, Birmingham Heersink School of Medicine, New York University, Health, Comprehensive Transplant Institute, , UAB, NYU, NYU Langone Transplant Institute, CNN Health, Liver Transplant, FDA, US Department of Health, Human, Transplantation Network
The New York Times reports NYU Langone gave "VIPs" like donors and trustees preferential treatment. NYU Langone broadly denied the claims in a statement to Insider. Langone told the Times that he never asked for or was offered special treatment. Ambulance workers who brought these patients to NYU Langone were sometimes pressured to take them elsewhere, the report says. New York Senator Chuck Schumer once went into Room 20 with his wife, who was experiencing shortness of breath, the Times reported.
RA Capital is one of the few mainstream biotech VCs wading into the psychedelics space. The number of companies touting the benefits of psychedelics for healthcare is rapidly growing, but not all biotech investors are on board yet. Last year RA Capital made two investments into the psychedelics spaceIn 2021, RA made its first investments into the psychedelics space by funding two startups: GH Research and Delix Therapeutics. Dublin, Ireland-based GH Research is one of the only psychedelics companies to have garnered a flurry of interest from mainstream healthcare investors including RA Capital, RTW Investments, and BVF Partners. Lusaris' treatment is designed to be taken sublingually — placed under the tongue — for treatment-resistant depression.
Johns Hopkins University, Yale University, and New York University announced on Thursday they were collaborating to create a psychedelics curriculum for psychiatrists. Benjamin Kelmendi is an assistant professor of psychiatry at Yale University and a codirector of the Yale Program for Psychedelic Science. YaleNYU's Ross told Insider it was "daunting" to think about the sheer number of therapists that needed to be trained to expand access for patients. Researchers are working to fill the gap that exists between psychedelics and the medical systemChristopher Pittenger is a codirector at the Yale Program for Psychedelic Science. YaleDr. Benjamin Kelmendi, a codirector of the Yale Program for Psychedelic Science, told Insider that he saw psychedelics as having broad applications that will attract other branches of medicine.
Total: 5